Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Partners to Develop Methodologies for Ensuring Quality of Stem Cell Production

By BiotechDaily International staff writers
Posted on 12 Nov 2012
Biotech companies from the United States and Europe have recently announced an agreement to cooperate on the development of methodologies to enable the consistent production of large quantities of stem cells for research and clinical use.

The American company EMD Millipore (Billerica, MA, USA) offers a broad range of innovative products, services, and business relationships in research, development, and production of biotech and pharmaceutical drug therapies. EMD Millipore is the life science division of Merck KGaA, (Darmstadt, Germany).

The other partner to the agreement is Sistemic Ltd. (Glasgow, United Kingdom). Sistemic is a leading provider of microRNA-based problem-solving services and kit-based products. Their extensive suite of tools for the cell therapy community includes SistemQCT, which is used to characterize cells including stem cells with regard to cell identity, purity, potency, and safety as well as monitoring production quality control. In addition, the drug development market is served through a range of products which include SistemTOXT, SistemKBT, and SistemRNAT.

Under terms of the newly announced agreement the companies will jointly develop proprietary monitoring methodology utilizing Sistemic's microRNA marker detection capability to enable consistent growth of stem cells in EMD Millipore's Mobius CellReady platform. Markers developed in the course of this project may also be incorporated into commercially available kits for quality control of stem cells cultures.

"To advance the progress of stem cell products toward clinical use, it is critical to ensure the consistency and quality of large-scale culture systems," said Robert Shaw, commercial director of EMD Millipore's Stem Cell Initiative. "We are excited to be partnering with Sistemic, as the company's leading microRNA-based solutions will help us continue our efforts toward the commercialization of stem cell processing."

"We are delighted to enter this collaborative arrangement with EMD Millipore," said Jim Reid, CEO of Sistemic. "The fact that EMD Millipore has chosen Sistemic as its collaborative partner is yet another validation of our ground-breaking research and ability to develop systems for quality control of stem cells, and other mutually beneficial products and programs."

Related Links:
EMD Millipore
Merck KGaA
Sistemic Ltd.


Channels

Genomics/Proteomics

view channel
Image: The photo shows a mouse pancreatic islet as seen by light microscopy. Beta cells can be recognized by the green insulin staining. Glucagon is labeled in red and the nuclei in blue (Photo courtesy of Wikimedia Commons).

Regenerative Potential Is a Trait of Mature Tissues, Not an Innate Feature of Newly Born Cells

Diabetes researchers have found that the ability of insulin-producing beta cells to replicate and respond to elevated glucose concentrations is absent in very young animals and does not appear until after weaning.... Read more

Drug Discovery

view channel
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).

Human Heart-on-a-Chip Cultures May Replace Animal Models for Drug Development and Safety Screening

Human heart cells growing in an easily monitored silicon chip culture system may one day replace animal-based model systems for drug development and safety screening. Drug discovery and development... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.